What's in Ping-Yen Liu's pipeline?

Ping-Yen Liu has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ping-Yen Liu's portfolio?

Top competitors by shared drug class: First Affiliated Hospital of Harbin Medical University, Fu Wai Hospital, Beijing, China, Samsung Medical Center, St. Antonius Hospital, University of Florida.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ping-yen-liu.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Ping-Yen Liu — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ping-Yen Liu pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Clopidogrel first	Clopidogrel first	marketed
Ticagrelor first	Ticagrelor first	marketed	P2Y12 receptor antagonist	P2Y12	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

First Affiliated Hospital of Harbin Medical University · 1 shared drug class
Fu Wai Hospital, Beijing, China · 1 shared drug class
Samsung Medical Center · 1 shared drug class
St. Antonius Hospital · 1 shared drug class
University of Florida · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ping-Yen Liu:

Cite this brief

Drug Landscape (2026). Ping-Yen Liu — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ping-yen-liu. Accessed 2026-06-09.